Literature DB >> 26717914

Physiological and Histological Evaluations of the Cochlea between 3xTg-AD Mouse Model of Alzheimer's Diseases and R6/2 Mouse Model of Huntington's Diseases.

Sheue-Er Wang1, Chung-Hsin Wu1.   

Abstract

Patients with Alzheimer's diseases (AD) and Huntington's diseases (HD) are known to have abnormal auditory processing, but the physiological and histological evaluations of the cochlea between AD and HD have not been thoroughly assessed. Thus we assessed the auditory brainstem response (ABR) and distortion product otoacoustic emissions (DPOAE), and then examined spiral ganglion neurons (SGNs) and hair cells in the cochlea using 3xTg-AD mouse model of AD and R6/2-HD mouse model of HD. We found that the threshold of ABR, but not DPOAE, was significantly increased in AD mice from 9 months of age and thereafter. The significant loss of SGNs, but not hair cells, was observed in the cochlea of 9- and 12-month AD mice. On the other hand, we found that both ABR and DPOAE thresholds were significantly increased in HD mice from 2 months of age and thereafter. The large loss of hair cells and the small loss of SGNs were observed in the cochlea of 3-month HD mice. Furthermore, the prestin expression in outer hair cells (OHCs) was significantly decreased in HD mice from 2 months of age and thereafter, and the loss of prestin expression was earlier before OHCs death in HD mice. Different from HD mice, the prestin expression in OHCs in AD mice was not changed even at 12 months of age. Our data suggest that cochlear pathology contributing to hearing loss is quite different between transgenic mice of AD and HD. More detailed pathological mechanisms for hearing loss between AD and HD need further study.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26717914     DOI: 10.4077/CJP.2015.BAD334

Source DB:  PubMed          Journal:  Chin J Physiol        ISSN: 0304-4920            Impact factor:   1.764


  5 in total

1.  Hearing loss is an early biomarker in APP/PS1 Alzheimer's disease mice.

Authors:  Yang Liu; Shu Fang; Li-Man Liu; Yan Zhu; Chang-Ri Li; Kaitian Chen; Hong-Bo Zhao
Journal:  Neurosci Lett       Date:  2019-12-20       Impact factor: 3.046

Review 2.  Mitochondrial Dysfunction and Therapeutic Targets in Auditory Neuropathy.

Authors:  Baoyi Feng; Chenxi Jin; Zhenzhe Cheng; Xingle Zhao; Zhuoer Sun; Xiaofei Zheng; Xiang Li; Tingting Dong; Yong Tao; Hao Wu
Journal:  Neural Plast       Date:  2020-08-28       Impact factor: 3.599

3.  Alterations in Retinal Signaling Across Age and Sex in 3xTg Alzheimer's Disease Mice.

Authors:  Gabrielle Frame; Adam Schuller; Matthew A Smith; Samuel D Crish; Christine M Dengler-Crish
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

Review 4.  Cognitive Decline, Dementia, Alzheimer's Disease and Presbycusis: Examination of the Possible Molecular Mechanism.

Authors:  Yilin Shen; Bin Ye; Penghui Chen; Quan Wang; Cui Fan; Yilai Shu; Mingliang Xiang
Journal:  Front Neurosci       Date:  2018-06-08       Impact factor: 4.677

5.  Proteasome Activity in the Plasma as a Novel Biomarker in Mild Cognitive Impairment with Chronic Tinnitus.

Authors:  Yejin Yun; Sang-Yeon Lee; Won Hoon Choi; Jong-Chan Park; Dong Han Lee; Yun Kyung Kim; Jung Hoon Lee; Jun-Young Lee; Min Jae Lee; Young Ho Kim
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.